# Drug-eluting Stents vs. Drug-coated Balloon for Preventing Recurrent In-stent Restenosis

> **NCT01967199** · PHASE4 · TERMINATED · sponsor: **Seung-Jung Park** · enrollment: 175 (actual)

## Conditions studied

- Coronary Restenosis

## Interventions

- **DEVICE:** Everolimus-eluting balloon expandable stent
- **DEVICE:** paclitaxel eluting balloon

## Key facts

- **NCT ID:** NCT01967199
- **Lead sponsor:** Seung-Jung Park
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-04-18
- **Primary completion:** 2017-02-14
- **Final completion:** 2017-02-14
- **Target enrollment:** 175 (ACTUAL)
- **Last updated:** 2017-02-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01967199

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01967199, "Drug-eluting Stents vs. Drug-coated Balloon for Preventing Recurrent In-stent Restenosis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01967199. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*